{"id":"https://openalex.org/W2980193530","doi":"https://doi.org/10.1182/blood.v126.23.2739.2739","title":"Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab Following Standard Chemotherapy for Patients with Intermediate-High/High Risk Diffuse Large B-Cell Lymphoma (DLBCL) - Final Results","display_name":"Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab Following Standard Chemotherapy for Patients with Intermediate-High/High Risk Diffuse Large B-Cell Lymphoma (DLBCL) - Final Results","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2980193530","doi":"https://doi.org/10.1182/blood.v126.23.2739.2739","mag":"2980193530"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.2739.2739","doi":"https://doi.org/10.1182/blood.v126.23.2739.2739","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2739.2739","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085325467","display_name":"Nishitha M Reddy","orcid":"https://orcid.org/0000-0002-6059-9647","observed_orcids":["https://orcid.org/0000-0002-6059-9647"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nishitha M Reddy","raw_affiliation_strings":["Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062578515","display_name":"David Morgan","orcid":"https://orcid.org/0000-0002-6959-5079","observed_orcids":["https://orcid.org/0000-0002-6959-5079"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David S Morgan","raw_affiliation_strings":["Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002767460","display_name":"John P. Greer","orcid":"https://orcid.org/0000-0001-7997-0285","observed_orcids":["https://orcid.org/0000-0001-7997-0285"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John P Greer","raw_affiliation_strings":["Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013004380","display_name":"Heidi Chen","orcid":"https://orcid.org/0000-0002-1841-6747","observed_orcids":["https://orcid.org/0000-0002-1841-6747"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Heidi Chen","raw_affiliation_strings":["Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904385","display_name":"Steven I. Park","orcid":"https://orcid.org/0000-0001-5674-6408","observed_orcids":["https://orcid.org/0000-0001-5674-6408"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven I. Park","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054381821","display_name":"Kristy L. Richards","orcid":"https://orcid.org/0000-0001-5765-6631","observed_orcids":["https://orcid.org/0000-0001-5765-6631"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristy L. Richards","raw_affiliation_strings":["weill cornell medical college, New york,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"weill cornell medical college, New york,","institution_ids":["https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5013004380"],"corresponding_institution_ids":["https://openalex.org/I901861585"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.36936397,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"2739","last_page":"2739"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9810000061988831},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.996999979019165},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.972000002861023},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.7870000004768372},{"id":"https://openalex.org/keywords/international-prognostic-index","display_name":"International Prognostic Index","score":0.7739999890327454},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.6639999747276306},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8080000281333923},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.593999981880188},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.8399999737739563},{"id":"https://openalex.org/keywords/high-risk-lymphoma","display_name":"high-risk lymphoma","score":0.5680000185966492},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.6370000243186951},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.8889999985694885},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.3700000047683716},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.3070000112056732},{"id":"https://openalex.org/keywords/bulky-disease","display_name":"bulky disease","score":0.47699999809265137},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.4259999990463257}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7971563339233398},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7547681331634521},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7508946657180786},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6453851461410522},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.5709437727928162},{"id":"https://openalex.org/C2778476033","wikidata":"https://www.wikidata.org/wiki/Q1667625","display_name":"International Prognostic Index","level":4,"score":0.5219675898551941},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49139419198036194},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4751936197280884},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.41389861702919006},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38007810711860657},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3551476001739502},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2730652391910553},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.18080028891563416}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.2739.2739","doi":"https://doi.org/10.1182/blood.v126.23.2739.2739","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2739.2739","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6200000047683716}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2306115591","https://openalex.org/W2555304286","https://openalex.org/W2591042562","https://openalex.org/W4389229867","https://openalex.org/W2980030407","https://openalex.org/W2575094409","https://openalex.org/W2950297374","https://openalex.org/W2567689975","https://openalex.org/W2566347093","https://openalex.org/W2156764287"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"DLBCLpatients":[2],"(pts)":[3],"with":[4,30,95,148,191,240,399,405,412],"an":[5,14,36,134],"elevated":[6],"international":[7],"prognostic":[8,401],"index":[9],"(IPI)":[10],"score":[11],"are":[12],"at":[13,158,177],"increased":[15],"risk":[16,92],"of":[17,27,54,72,113,131,161,168,180,187,196,244,262,276,283],"disease":[18,218],"relapse":[19,132,137],"rate":[20],"in":[21,41,56,74,153,225,302,396],"the":[22,46,70,114,119,226,260,265,286,308,325],"first":[23],"year":[24,86,121],"after":[25],"completion":[26],"standard":[28,150,389],"therapy":[29,383],"rituximab":[31,55,107,192],"(R)":[32],"-CHOP.":[33],"Lenalidomide":[34,442],"(len),":[35],"immunomodulatory":[37],"drug,":[38],"has":[39],"activity":[40,71,387],"relapsed":[42],"DLBCL.":[43],"Len":[44,220,379],"enhances":[45],"natural":[47],"killer":[48],"cell":[49,58],"mediated":[50],"antibody-dependent":[51],"cellular":[52],"cytotoxicity":[53],"lymphoma":[57],"lines":[59],"and":[60,106,264,289,296,305,324,375,391,394],"inhibits":[61],"angiogenesis":[62],"as":[63,65,80,381,403],"well":[64],"alters":[66],"cytokine":[67],"production.":[68],"Given":[69],"len":[73,100,105,157,176],"DLBCL,":[75],"we":[76],"explored":[77],"this":[78],"combination":[79],"a":[81,128,159,178,241,280],"consolidative":[82],"approach":[83],"for":[84,165,184,211,217,257],"one":[85,120,212],"following":[87,388,443],"R-CHOP":[88],"therapy.":[89,151],"Methods:":[90],"Intermediate-high/high":[91],"IPI":[93,254],"patients":[94,258,271,301,398],"DLBCL":[96,397],"were":[97,223,250],"randomized":[98],"to":[99,117,202,274,348],"(arm":[101,108],"A)":[102],"alone":[103,380],"or":[104],"B).":[109],"The":[110,252,351],"primary":[111],"endpoint":[112],"study":[115],"was":[116,200,209,215,255,268,293,311,328],"assess":[118],"disease-free":[122],"survival":[123,291],"(DFS).":[124],"We":[125],"expected":[126,135],"that":[127],"25%":[129],"difference":[130],"from":[133],"40%":[136],"based":[138],"on":[139,172,193,206],"historical":[140,406],"controls":[141],"would":[142],"have":[143],"clinical":[144,386],"significance":[145],"when":[146],"compared":[147,404],"current":[149],"Patients":[152,171],"arm":[154,173,232,235,303,306],"A":[155,304],"received":[156,175,272],"dose":[160,179,221],"25":[162],"mg":[163,182],"daily":[164,183],"21":[166,185,237],"days":[167,186,189],"28":[169,188],"days.":[170],"B":[174,307],"20":[181],"along":[190],"day":[194],"8":[195],"even":[197],"cycles.":[198],"Aspirin":[199],"administered":[201],"all":[203],"patients.":[204],"Treatment":[205,214],"both":[207],"arms":[208],"continued":[210],"year.":[213],"discontinued":[216,345],"progression.":[219],"adjustments":[222],"incorporated":[224],"protocol.":[227],"Results:":[228],"Forty-four":[229],"pts,":[230],"22":[231,234],"A/":[233],"B,":[236],"female/23":[238],"male,":[239],"median":[242,253,266,281],"age":[243,261],"59.6":[245],"yrs":[246],"(range":[247],"19-85":[248],"yrs)":[249],"enrolled.":[251],"4":[256],"over":[259],"60":[263],"aa-IPI":[267],"3.":[269],"Three":[270],"radiation":[273],"areas":[275],"bulky":[277],"disease.":[278],"At":[279],"follow-up":[282],"3.64":[284],"years,":[285],"two-year":[287,309,326],"DFS":[288,310,393],"overall":[290],"(OS)":[292],"86%":[294,312,317,329],"(72%-94%)":[295],"91%":[297],"(77%-96%),":[298],"respectively.":[299],"For":[300],"(63%":[313],"-":[314,320,331,337],"95%)%":[315,321,332],"vs.":[316,333],"(":[318,335],"62%":[319],"(figure":[322,339],"1)":[323],"OS":[327,395],"(62%":[330],"95%":[334],"72%":[336],"99%)%":[338],"2),":[340],"respectively":[341],"(P=NS).":[342],"Two":[343],"pts":[344],"treatment":[346],"due":[347],"adverse":[349],"events.":[350],"most":[352],"common":[353],"grade":[354,367],"3-4":[355],"toxicities":[356,369],"include":[357,370],"neutropenia":[358],"(57%),":[359],"fatigue":[360],"(9%),":[361],"diarrhea":[362],"(8%),":[363],"rash":[364,376],"(1%).":[365],"Related":[366],"1-2":[368],"endocrine":[371],"abnormalities":[372],"[hypo/hyperthyroidism]":[373],"(29.5%)":[374],"(65%).":[377],"Conclusions:":[378],"maintenance":[382],"demonstrates":[384],"significant":[385],"chemotherapy":[390],"improves":[392],"high-risk":[400],"features":[402],"controls.":[407],"This":[408],"trial":[409],"is":[410],"registered":[411],"NCI-":[413],"#NCT00765245":[414],"Figure":[415,417,419,421],"1.":[416,418],"2.":[420,422],"Disclosures":[423],"Reddy:":[424],"ImmunoGen:":[425],"Consultancy;":[426,428,434],"PCYC:":[427],"Gilead:":[429],"Other:":[430,453],"Speaker;":[431],"Seattle":[432,448],"Genetics:":[433,449],"Celgene:":[435],"Consultancy,":[436],"Research":[437,446,450],"Funding.":[438],"Off":[439],"Label":[440],"Use:":[441],"R-CHOP.":[444],"Park:TEVA:":[445],"Funding;":[447,451],"Jannsenn:":[452],"Travel.":[454]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2019-10-18T00:00:00"}